StockSelector.com
  Research, Select, & Monitor Thursday, April 19, 2018 11:11:26 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Arrowhead Pharmaceuticals, Inc.$6.91($.10)(1.43%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Arrowhead Pharmaceuticals, Inc. has an overall rank of 3135 out of 6928 stocks based on 7 positive rankings and 6 negative rankings.

Positive Rankings
Historic Revenue Growth
Arrowhead Pharmaceuticals rank is 18
Low vPut/Call
Arrowhead Pharmaceuticals has a low Put/Call ratio of 0.04 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Arrowhead Pharmaceuticals is ranked 89.
90 Day Gain
Arrowhead Pharmaceuticals rank is 122
Low Put/Call
Arrowhead Pharmaceuticals has a low Put/Call ratio of 0.16 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Arrowhead Pharmaceuticals is ranked 376.
Debt-to-Equity
Arrowhead Pharmaceuticals rank is 601
Estimated Revenue Growth
Arrowhead Pharmaceuticals rank is 912
Highest Cash Growth
Arrowhead Pharmaceuticals rank is 1418
Negative Rankings
Price-to-Sales
Arrowhead Pharmaceuticals rank is 303
Negative Net Margin
Arrowhead Pharmaceuticals rank is 411
Negative ROE
Arrowhead Pharmaceuticals rank is 613
Negative ROA
Arrowhead Pharmaceuticals rank is 617
Price-to-Book
Arrowhead Pharmaceuticals rank is 702
10 Day Loss
Arrowhead Pharmaceuticals rank is 857







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.